Research Article
Outcomes following Serial Intragastric Balloon Therapy for Obesity and Nonalcoholic Fatty Liver Disease in a Single Centre
Table 2
Clinical outcomes at 6 months.
| Clinical parameter | Baseline | 6 months (after IGB removal) | Mean difference | p value |
| Weight (kg) | 117.9 | 106.6 | 11.3 | <0.01 | BMI (kg/m2) | 41.7 | 37.6 | 4.1 | <0.01 | Waist circumference (cm) | 124.2 | 101.1 | 23.1 | 0.04 | Fasting BSL (mmol/L) | 6.0 | 5.4 | 0.6 | 0.12 | Fasting insulin (mIU/L) | 136.0 | 96.5 | 39.5 | 0.12 | HOMA-IR | 3.6 | 2.6 | 1.0 | 0.03 | ALT (IU/L) | 38.9 | 31.0 | 7.9 | <0.01 | AST (IU/L) | 35.1 | 32.8 | 2.3 | 0.11 | GGT (IU/L) | 62.6 | 39.1 | 23.5 | <0.01 | Fasting cholesterol (mmol/L) | 4.8 | 5.1 | | 0.08 | Fasting LDL (mmol/L) | 2.7 | 2.8 | | 0.09 | Fasting HDL (mmol/L) | 1.2 | 1.5 | ā0.3 | 0.39 | Fasting triglycerides (mmol/L) | 1.8 | 1.4 | 0.4 | 0.22 |
|
|
A significant difference in ALT and GGT was noted at follow-up in those with an elevated HOMA-IR score (i.e., insulin resistance) at baseline.
|